Effectiveness and Safety of High- vs Low-Dose Swallowed Topical Steroids for Maintenance Treatment of Eosinophilic Esophagitis: A Multicenter Observational Study is a research paper published in Clinical Gastroenterology and Hepatology (2020). On theSindex it has a DataRank of 0. It has been cited 45 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Grant: 32003B_135665/1
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Grant: P2ZHP3_168561
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Grant: 32003B_160115
Swiss National Science Foundation
Grant: 135665
Development, Validation and Evaluation of an Adult and Pediatric Eosinophilic Esophagitis Activity Index: A Prospective Multicenter Study
NIAID NIH HHS
Grant: U54 AI117804
NCATS NIH HHS
Grant: U2C TR002818
Swiss National Science Foundation
Grant: 160115
Defining clinically meaningful therapeutic endpoints in Eosinophilic Esophagitis
National Institutes of Health
Grant: 5U54AI117804-03
Consortium of Eosinophilic Gastrointestinal Disease Researchers
National Institutes of Health
Grant: 5U2CTR002818-03
Data Management and Coordinating Center: Rare Diseases Clinical Research Network
Swiss National Science Foundation
Grant: 168561
SYNECTIN PROMOTES LIVER FIBROSIS BY INCREASING PDGFRa SIGNALING IN VITRO AND IN VIVO
Shire
Grant: unidentified
unidentified
Shire
National Institute of Diabetes and Digestive and Kidney Diseases
National Center for Advancing Translational Sciences
Novartis Foundation
Novartis Stiftung für Medizinisch-Biologische Forschung
National Institutes of Health
National Institute of Allergy and Infectious Diseases
Eli Lilly and Company
FWCI
4.11
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals